Topotecan Hydrochloride 45963-0615
Product NDC
45963-0615- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 5, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA090620
Need to source Topotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topotecan Hydrochloride | 4 mg/4mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Packaging Options(1)
1 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL